Showstopper Healthcare Earnings Elevate Use Case for XLV
Wednesday, August 5th may have felt like an average Summer day, but it actually represented a compelling inflection point for the healthcare industry. This is because a few key healthcare giants reported their Q2 2026 results, showing that the industry still has plenty of gas left in the tank.
Drug Pipeline Wins State Street Over on Healthcare
State Street Investment Management is turning positive on healthcare stocks after nearly a year of caution. The firm's Q3 2026 sector outlook upgraded healthcare from neutral to positive.
Not Just Tech: Invest in Innovation With Healthcare
Traditionally speaking, folks that have looked to tap into innovation in the AI space have done so through tech exposure, particularly with mega-cap names. This is not a surprise, considering the interplay between these companies and AI innovation.
Should You Invest in the State Street Health Care Select Sector SPDR ETF ETF (XLV)?
If you're interested in broad exposure to the Healthcare - Broad segment of the equity market, look no further than the State Street Health Care Select Sector SPDR ETF ETF (XLV), a passively managed exchange traded fund launched on December 16, 1998.
The 2 Factors That Will Decide Whether XLV Finally Catches the S&P 500 in 2026
The Health Care Select Sector SPDR ETF (NYSEARCA:XLV) is having a frustrating year.
When 2022 Tore Through the S&P 500, This Healthcare ETF Barely Flinched. Why Isn't It in More Retirement Accounts?
Tony Dong is the founder of ETF Portfolio Blueprint.
Why the Healthcare Sector Warrants Concentrated Exposure
Sure, portfolio diversification may be important, but some equity sectors currently look a bit more promising than others. Key Takeaways: Diversification may be a valuable portfolio approach, but individual equity sectors like healthcare may warrant concentrated exposure.
Healthcare's Defensive Promise Crumbles: XLV Down 7% While SPY Rises 5% in 2026
Healthcare is supposed to be the place you hide. It is the fourth-largest slice of U.S.
When the Market Sold Off in 2022, This Healthcare ETF Beat the S&P 500 by 16 Percentage Points. With Volatility Back, That History Is Worth Revisiting
Healthcare is not always the most exciting sector to own, and the companies in it grind it out, quarter after quarter, raise dividends quietly, and generally do not produce the kind of explosive returns that technology stocks have delivered in the best years of the past decade.
Should You Invest in the State Street Health Care Select Sector SPDR ETF ETF (XLV)?
Launched on December 16, 1998, the State Street Health Care Select Sector SPDR ETF ETF (XLV) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare - Broad segment of the equity market.
XLV is A $41 Billion Defensive Healthcare Play That Looks Good Until You Compare To The S&P 500
Healthcare isn't going anywhere. An aging population, chronic disease management, and breakthrough treatments ensure this sector remains essential regardless of market conditions.
Should You Invest in the State Street Health Care Select Sector SPDR ETF ETF (XLV)?
The State Street Health Care Select Sector SPDR ETF ETF (XLV) was launched on December 16, 1998, and is a passively managed exchange traded fund designed to offer broad exposure to the Healthcare - Broad segment of the equity market.
